AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Jyske Bank

Transaction in Own Shares Dec 15, 2025

3370_pos_2025-12-15_53a5c42d-a0ca-4ce6-845e-e586edc9266d.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

The share repurchase programme runs as from 26 February 2025 and up to and including 30 January 2026 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 2.25 billion, cf. Corporate Announcement No. 3/2025 of 26 February 2025. The share repurchase programme is initiated and structured in compliance with the EU Commission Regulation No. 596/2014 of 16 April 2014, the so-called “Market Abuse Regulation”, and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the "Safe Harbour Rules").

The following transactions have been made under the program:

Number of

shares
Average purchase

price (DKK)
Transaction

value (DKK)
Accumulated, previous announcement 2,836,419 646.89 1,834,846,129
8 December 2025 14,815 811.82 12,027,140
9 December 2025 14,943 810.76 12,115,208
10 December 2025 14,869 812.50 12,081,030
11 December 2025 15,000 819.43 12,291,426
12 December 2025 15,000 825.20 12,377,942
Accumulated under the programme 2,911,046 651.22 1,895,738,874

Following settlement of the transactions stated above, Jyske Bank will own a total of 2,911,046 of treasury shares, excluding investments made on behalf of customers and shares held for trading purposes, corresponding to 4.73% of the share capital.

Attached to this corporate announcement, aggregated details on the transactions related to the share repurchase programme are shown by venue.

Yours faithfully,

Jyske Bank

Contact: Birger Krøgh Nielsen, CFO, tel. +45 89 89 64 44.

Attachment

Talk to a Data Expert

Have a question? We'll get back to you promptly.